| | |
| Pet pig Nemo's lymphoma treatment makes research history Wednesday, Jul 24, 2013 11:31 AM PDT By Yasmeen Abutaleb WASHINGTON (Reuters) - When George Goldner went to feed his six pet pigs earlier this year, his 730-pound (331-kg) companion Nemo was acting strangely. Nemo had suddenly stopped eating and laid in the mud. So Goldner loaded Nemo into a trailer and drove more than two hours to Cornell University Hospital for Animals (CUHA) in Ithaca, New York. There he learned his four-year-old Hampshire pig had what doctors believed was the blood cancer B-cell lymphoma. The hospital's researchers told Goldner they had never seen a pig treated for cancer. ... Full Story | Top |
| Insurer WellPoint sees $20 billion Obamacare opportunity Wednesday, Jul 24, 2013 11:25 AM PDT By Caroline Humer (Reuters) - WellPoint Inc , the nation's second largest health insurer, sees President Barack Obama's healthcare reform giving a $20 billion boost to its revenue by 2016, led by an expansion of the Medicaid program for the poor and the introduction of subsidized coverage for the uninsured. WellPoint will be one of the largest players on health insurance exchanges created by the Affordable Care Act that will allow consumers to choose subsidized health plans beginning on October 1. ... Full Story | Top |
| Anglo American silicosis claimants turn to South African courts Wednesday, Jul 24, 2013 11:15 AM PDT JOHANNESBURG (Reuters) - A British court has thrown out a lawsuit against Anglo American South Africa brought by miners who contracted the deadly lung disease silicosis when they worked in South Africa, saying it did not have jurisdiction to hear the matter. A lawyer for the 2,336 miners said on Wednesday many of them planned to file papers in the next few days in South Africa seeking damages against the South African unit of the global mining giant. ... Full Story | Top |
| No clear benefit of single incision surgery: ob-gyns Wednesday, Jul 24, 2013 11:05 AM PDT By Kerry Grens NEW YORK (Reuters Health) - Research so far has not found obvious advantages to minimally invasive surgery involving just one cut, according to a leading organization of women's doctors. Although single incision surgeries have become more popular in recent years, the evidence does not show they are any better for patients' health than other minimally invasive procedures, said Dr. Jessica Shepherd, one of the authors of the report from the American College of Obstetricians and Gynecologists (ACOG). ... Full Story | Top |
| Obama seeks second-term jolt with economic speech Wednesday, Jul 24, 2013 11:05 AM PDT  By Roberta Rampton GALESBURG, Illinois (Reuters) - U.S. President Barack Obama sought to inject momentum into his economic and domestic policy agenda on Wednesday with a speech designed to clarify his vision for his second term and hammer Republicans in the House of Representatives for getting in his way. Obama defended his government's record managing the economy through the recession in his first term and said new spending on infrastructure and education were needed now to grow the middle class, which he argued would boost the nation's economy. ... Full Story | Top |
| Sarepta stock falls over doubts of faster approval for lead drug Wednesday, Jul 24, 2013 10:00 AM PDT By Zeba Siddiqui (Reuters) - Sarepta Therapeutics Inc said data from ongoing studies of its lead drug could be enough for the company to apply for a U.S. approval, but that the regulator was unsure if it was enough to fast-track the review process, sparking a sell-off in the company's shares. ... Full Story | Top |
| French Senate lays bare doping in 1998 Tour de France Wednesday, Jul 24, 2013 09:43 AM PDT  By Alexandria Sage PARIS (Reuters) - The top two in the 1998 Tour de France - Italian Marco Pantani and Germany's Jan Ullrich - were taking the banned blood booster EPO, a French Senate inquiry into sports doping said on Wednesday. The medical stubs enclosed in the 918-page report, when compared against a separate list of test results, also reveal that American Lance Armstrong tested positive for EPO in 1999. ... Full Story | Top |
| Cycling-French Senate lays bare doping in 1998 Tour de France Wednesday, Jul 24, 2013 09:40 AM PDT (Adds WADA statement, Jalabert quote) * EPO found in Ullrich, Pantani in 1998 race * Group urges more prevention efforts, better cooperation * Results of 5-month probe comes days after 2013 Tour By Alexandria Sage PARIS, July 24 (Reuters) - The top two in the 1998 Tour de France - Italian Marco Pantani and Germany's Jan Ullrich - were taking the banned blood booster EPO, a French Senate inquiry into sports doping said on Wednesday. ... Full Story | Top |
| Lilly beats forecast, cuts costs before Cymbalta fades Wednesday, Jul 24, 2013 09:34 AM PDT By Ransdell Pierson (Reuters) - Eli Lilly and Co reported higher-than-expected quarterly earnings on Wednesday as it slashed costs ahead of generic competition later this year for its biggest product, antidepressant Cymbalta, and raised its 2013 profit view on plans for more streamlining. Shares of Lilly rose almost 3 percent as investors viewed the cost containment for research, marketing and other expenses in the second half of this year as an important move. ... Full Story | Top |
| Glaxo warns China corruption scandal will hit business Wednesday, Jul 24, 2013 08:45 AM PDT  By Ben Hirschler LONDON (Reuters) - A "shameful" corruption scandal in China will inevitably impact GlaxoSmithKline's business, the British drugmaker's chief executive said on Wednesday, adding he was ready to go to Beijing "at the right moment." In his first public comments since the crisis broke a fortnight ago, Andrew Witty said GSK would set up an independent review to investigate the "deeply disappointing" allegations. ... Full Story | Top |
| Ginseng supplements linked to less cancer fatigue Wednesday, Jul 24, 2013 07:58 AM PDT By Kathryn Doyle NEW YORK (Reuters Health) - Cancer patients and survivors who felt tired or sluggish reported feeling noticeably better after taking ginseng supplements for two months, in a new study. "Nearly all patients with cancer can suffer from fatigue at some point; either at diagnosis, during treatment and even after treatment, and (fatigue) can linger for several years," said lead author Debra Barton, from the Mayo Clinic in Rochester, Minnesota. ... Full Story | Top |
| Indian police arrest school principal in food poisoning case Wednesday, Jul 24, 2013 07:55 AM PDT  NEW DELHI (Reuters) - Indian police on Wednesday arrested the headmistress of a school where 23 children died after eating a meal laced with pesticide in one of India's deadliest food poisoning outbreaks in years. The woman, who had been missing for more than a week, was detained while on her way to court to surrender, said Sujit Kumar, superintendent of police in Saran district in the eastern state of Bihar. The children fell ill within minutes of eating a meal of rice and soybean-potato curry in their one-room school on July 16, vomiting and convulsing with stomach cramps. ... Full Story | Top |
| FDA accepts review of long-delayed Merck blood clot drug Wednesday, Jul 24, 2013 07:44 AM PDT (Adds Merck comment, share movement) By Ransdell Pierson July 24 - Merck & Co. on Wednesday said U.S. regulators had accepted its marketing application for the blood clot drug vorapaxar, aimed at preventing heart attacks and strokes in patients who have already had a heart attack but who have no history of stroke. The experimental drug, acquired by Merck through its 2009 acquisition of rival U.S. drugmaker Schering-Plough Corp., was once considered a potential blockbuster product. ... Full Story | Top |
| Syrian authorities blocking access to needy in Homs: Red Cross Wednesday, Jul 24, 2013 06:54 AM PDT  GENEVA (Reuters) - Syrian authorities are blocking access to the old city of Homs, where trapped civilians are in dire need of food and medical supplies, the Red Cross said on Wednesday, warning of possible "tragic" consequences. The International Committee of the Red Cross (ICRC) revealed last Friday that it was negotiating a humanitarian pause to be able to enter Homs, where President Bashar al-Assad's forces have been conducting a heavy offensive against rebels, with air and artillery strikes. ... Full Story | Top |
| Support high for travel screening to stem MERS spread: poll Wednesday, Jul 24, 2013 05:48 AM PDT By Patricia Reaney NEW YORK (Reuters) - Little is known about a SARS-like virus that has infected people in the Middle East, North Africa and Europe, but there is strong support around the globe for screening travelers to prevent the spread of the disease, according to a new poll. An Ipsos online survey of more than 19,000 people in 24 countries showed that fewer than half of people questioned knew much about the disease known as Middle East Respiratory Syndrome coronavirus, or MERS, which has infected 88 people and killed 45 people. ... Full Story | Top |
|
No comments:
Post a Comment